165 related articles for article (PubMed ID: 29039106)
21. Measurement and analysis of unbound drug concentrations.
Wright JD; Boudinot FD; Ujhelyi MR
Clin Pharmacokinet; 1996 Jun; 30(6):445-62. PubMed ID: 8792057
[TBL] [Abstract][Full Text] [Related]
22. Investigation of high-throughput ultrafiltration for the determination of an unbound compound in human plasma using liquid chromatography and tandem mass spectrometry with electrospray ionization.
Zhang J; Musson DG
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Oct; 843(1):47-56. PubMed ID: 16815762
[TBL] [Abstract][Full Text] [Related]
23. Microultrafiltration technique for drug-protein binding determination in plasma.
Shah VP; Wallace SM; Riegelman S
J Pharm Sci; 1974 Sep; 63(9):1364-7. PubMed ID: 4427256
[No Abstract] [Full Text] [Related]
24. Evaluation of methods to determine protein-binding of drugs. Equilibrium dialysis, ultrafiltration, ultracentrifugation, gel filtration.
Kurz H; Trunk H; Weitz B
Arzneimittelforschung; 1977 Jul; 27(7):1373-80. PubMed ID: 578456
[TBL] [Abstract][Full Text] [Related]
25. [Advances in the study of affinity selection-ultrafiltration/HPLC-MS].
Zhao HY; Zhang YZ; Xiao CL
Yao Xue Xue Bao; 2009 Oct; 44(10):1084-8. PubMed ID: 20055128
[TBL] [Abstract][Full Text] [Related]
26. Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences.
Pacifici GM; Viani A
Clin Pharmacokinet; 1992 Dec; 23(6):449-68. PubMed ID: 1458763
[TBL] [Abstract][Full Text] [Related]
27. Are existing standard methods suitable for the evaluation of nanomedicines: some case studies.
Gioria S; Caputo F; Urbán P; Maguire CM; Bremer-Hoffmann S; Prina-Mello A; Calzolai L; Mehn D
Nanomedicine (Lond); 2018 Mar; 13(5):539-554. PubMed ID: 29381129
[TBL] [Abstract][Full Text] [Related]
28. A new method for plasma citrate determination by reversed-phase high-performance liquid chromatography after ultrafiltration extraction: an example for bioequivalence evaluation of a medicinal endogenous substance.
Gu Y; Wang GJ; Sun JG; Zhang XY; Sai Y
Methods Find Exp Clin Pharmacol; 2008 Sep; 30(7):513-20. PubMed ID: 18985179
[TBL] [Abstract][Full Text] [Related]
29. Pretreatment of plasma samples by a novel hollow fiber centrifugal ultrafiltration technique for the determination of plasma protein binding of three coumarins using acetone as protein binding releasing agent.
Li J; Shi Q; Jiang Y; Liu Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Sep; 1001():114-23. PubMed ID: 26276065
[TBL] [Abstract][Full Text] [Related]
30. Validation of 96-well equilibrium dialysis with non-radiolabeled drug for definitive measurement of protein binding and application to clinical development of highly-bound drugs.
Zamek-Gliszczynski MJ; Ruterbories KJ; Ajamie RT; Wickremsinhe ER; Pothuri L; Rao MV; Basavanakatti VN; Pinjari J; Ramanathan VK; Chaudhary AK
J Pharm Sci; 2011 Jun; 100(6):2498-507. PubMed ID: 21213309
[TBL] [Abstract][Full Text] [Related]
31. Prediction of drug concentrations in human skim milk from plasma protein binding and acid-base characteristics.
Atkinson HC; Begg EJ
Br J Clin Pharmacol; 1988 Apr; 25(4):495-503. PubMed ID: 3382591
[TBL] [Abstract][Full Text] [Related]
32. Protein binding of drugs.
Heald AF; Singhvi SM
Ann Clin Lab Sci; 1978; 8(3):239-43. PubMed ID: 655609
[TBL] [Abstract][Full Text] [Related]
33. Errors in interpretation of data from equilibrium dialysis protein binding experiments.
Behm HL; Wagner JG
Res Commun Chem Pathol Pharmacol; 1979 Oct; 26(1):145-60. PubMed ID: 515500
[TBL] [Abstract][Full Text] [Related]
34. [Ultrafiltration as a fast and simple method for determination of free and protein bound prilocaine concentration. Clinical study following high-dose plexus anesthesia].
Bachmann-Mennenga B; Biscoping J; Schürg R; Sinning E; Hempelmann G
Arzneimittelforschung; 1991 May; 41(5):520-4. PubMed ID: 1898423
[TBL] [Abstract][Full Text] [Related]
35. A pressure ultrafiltration method for serum free drug determination. Comparison with equilibrium dialysis using normal and uraemic sera.
Tiula E
Methods Find Exp Clin Pharmacol; 1984 Jan; 6(1):51-5. PubMed ID: 6717171
[TBL] [Abstract][Full Text] [Related]
36. The bioanalytical challenge of determining unbound concentration and protein binding for drugs.
Nilsson LB
Bioanalysis; 2013 Dec; 5(24):3033-50. PubMed ID: 24320129
[TBL] [Abstract][Full Text] [Related]
37. A dialysis-based in vitro drug release assay to study dynamics of the drug-protein transfer of temoporfin liposomes.
Wallenwein CM; Nova MV; Janas C; Jablonka L; Gao GF; Thurn M; Albrecht V; Wiehe A; Wacker MG
Eur J Pharm Biopharm; 2019 Oct; 143():44-50. PubMed ID: 31421208
[TBL] [Abstract][Full Text] [Related]
38. Determination of total and unbound concentrations of lopinavir in plasma using liquid chromatography-tandem mass spectrometry and ultrafiltration methods.
Illamola SM; Labat L; Benaboud S; Tubiana R; Warszawski J; Tréluyer JM; Hirt D
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Aug; 965():216-23. PubMed ID: 25049210
[TBL] [Abstract][Full Text] [Related]
39. Drug release from nanomedicines: Selection of appropriate encapsulation and release methodology.
Wallace SJ; Li J; Nation RL; Boyd BJ
Drug Deliv Transl Res; 2012 Aug; 2(4):284-92. PubMed ID: 23110256
[TBL] [Abstract][Full Text] [Related]
40. Vacuum ultrafiltration sampling for determination of plasma protein binding of drugs.
Lam H; Davies M; Lunte CE
J Pharm Biomed Anal; 1996 Sep; 14(12):1753-7. PubMed ID: 8887723
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
